Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
(IRWD)
Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Duzallo
Allopurinol
,
Lesinurad
2017-08-18
2025-2032
Hyperuricemia
,
Gout
Zurampic
Lesinurad
2015-12-22
2025-2032
Hyperuricemia
,
Gout
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lesinurad
chronic renal insufficiency
,
kidney diseases
,
gout
Allopurinol
chronic renal insufficiency
,
kidney diseases
,
gout
Senna
constipation
,
healthy volunteers/patients
Antithrombin iii
constipation
,
irritable bowel syndrome
,
syndrome
Enoblituzumab
constipation
Ademetionine
irritable bowel syndrome
,
constipation
,
syndrome
RECANACLOTIDE
gastroparesis
,
gastrointestinal diseases
,
dyspepsia
,
digestive system diseases
Corticoids
chronic renal insufficiency
,
kidney diseases
,
gout
Pbs
interstitial cystitis
,
syndrome
,
cystitis
,
somatoform disorders
Maltodextrin
constipation
Pariet
gastroesophageal reflux
,
peptic esophagitis
Replens
constipation
,
healthy volunteers/patients
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use